Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Donald S. Robinson, MD
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder
April 15, 2011
Arif Khan
,
Andrew J. Cutler
,
Daniel K. Kajdasz
, et al
JCP
Original Research
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
March 10, 2009
Karl Rickels
,
Maria Athanasiou
,
Donald S. Robinson
, et al
JCP
Original Research
Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials
December 14, 2007
Arif Khan
,
Kelly Schwartz
,
Chelsea Stern
, et al
JCP
Original Research
Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial
September 15, 2006
Alan D. Feiger
,
Karl Rickels
,
Moira A. Rynn
, et al
